The efficacy, safety, and tolerability of an estrogen-free oral contraceptive drospirenone 4  mg (24/4-day regimen) in obese users

This study aimed to compare contraceptive efficacy and safety of drospirenone 4  mg in a 24/4-day regimen in nonobese and obese users and describe pharmacokinetics according to bodyweight.
Source: Contraception - Category: OBGYN Authors: Tags: Original Research Article Source Type: research